Archives by Month:
- December 2024
- November 2024
- October 2024
- September 2024
- August 2024
- July 2024
- June 2024
- May 2024
- April 2024
- March 2024
- January 2024
- December 2023
- November 2023
- October 2023
- August 2023
- July 2023
- June 2023
- May 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- July 2016
- June 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- November 2012
- October 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- June 2009
- April 2009
- February 2009
- December 2008
- November 2008
- October 2008
- August 2008
- June 2008
- May 2008
Archives by Year:
As Expected, Manufacturing Activity Slows
It was pretty widely expected that the ISM Manufacturing report for the month of October was going to show a slower rate of growth, and that’s exactly what we saw. While economists were forecasting the headline index to drop to 59.0 from last month’s reading of 59.8, the actual reading was much weaker at 57.7. […]
5 Beaten Down Stocks Of Spooky October With Upside Potential
Wall Street witnessed wild swings in October, thanks to multiple woes including rising interest rates, political turbulence in Italy, Saudi tensions, tech sell-off, escalating US-China trade war and the prelude to mid-term election. The chaos resulted in S&P 500 posting its worst monthly performance since 2011. After slipping into a correction territory, the index rebounded […]
5 Reasons For The Downfall Of The Dollar
The US Dollar is on the back foot at the wake of the new month. There are several reasons for the downfall. This may continue if the Non-Farm Payrolls report misses expectations. Here are five reasons for the downfall of the Dollar: 1) Optimism on trade US President Donald Trump said that he had a […]
US Manufacturing Slumps As Prices Jump, Export Orders Dump, Financial Conditions Tighten
Despite drastically tightening financial conditions, ‘soft’ survey data on US Manufacturing was expected to rise in October, but – as always – it was mixed: Markit’s Manufacturing PMI printed higher at 55.7 (marginally higher than September’s 55.6 but below the October flash print of 55.9) ISM Manufacturing Printed dramatically lower at 57.7 (well below expectations of 59.0 and […]
Ebay Focusing On Payments
According to an eMarketer report published earlier this year, online retailer Amazon is expected to account for 49% of the US e-commerce market by the end of the year. Rival eBay (Nasdaq: EBAY ) comes in a distant second with a modest 6.6% market share. The report estimates total US e-commerce sales to be nearly $253 billion […]
Soybeans Looking Interesting… Confirming Dollar Weakness? Hmmm…
Soybeans (Jan ‘19)…240-min view…impulse down complete? US Dollar Index into our target zone…turning down?
Is The Fed Engineering A Market Crash?
Can the Fed cause a market crash? In 2017 Fed Chair Janet Yellen reassured us: “Would I say there will never, ever be another financial crisis? …. That would be going too far but I do think we’re much safer and I hope that it will not be in our lifetimes and I don’t believe it will […]
3Q2018 (Preliminary): Headline Productivity Improves
A simple summary of the headlines for this release is that productivity improved while the labor costs grew. Year-over-year analysis shows labor costs rising marginally faster than productivity. Analyst Opinion of Productivity and Costs I only look at year-over-year data – the headline compounding distorts the view. I have issues with the way productivity is […]
Jobless Claims Edge Slightly Lower
Jobless claims saw only a slight decline last week falling from 216K down to 214K, which was just a tad above consensus expectations for a decline to 212K. While claims have increased 12K from their low print in mid-September, they have now been at or below 300K for a record 191 straight weeks, at or […]
Teva Beats On Q3 Earnings, Lags Sales, Shares Up
Israel-based Teva Pharmaceutical Industries Ltd. (TEVA – Free Report) is a global pharmaceutical company with a strong presence in the generics as well as branded markets. The company’s branded products include Copaxone (multiple sclerosis), Azilect (Parkinson’s disease), Austedo (chorea associated with Huntington’s disease and tardive dyskinesia) and respiratory products like ProAir and Qvar. Teva is facing significant challenges in […]
